image
Healthcare - Biotechnology - NASDAQ - US
$ 0.5209
-5.54 %
$ 44.9 M
Market Cap
-0.33
P/E
CASH FLOW STATEMENT
-110 M OPERATING CASH FLOW
-24.66%
47.5 M INVESTING CASH FLOW
-22.33%
74.6 M FINANCING CASH FLOW
866.71%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Century Therapeutics, Inc.
image
00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)(120m)(120m)(140m)(140m)202020202021202120222022202320232024202420252025
Net Income -127 M
Depreciation & Amortization 13.3 M
Capital Expenditures 0
Stock-Based Compensation 12.7 M
Change in Working Capital -9.28 M
Others -8.96 M
Free Cash Flow -110 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
OPERATING CASH FLOW
Net Income (126.6) (136.7) (130.9) (95.8) (53.6) (244.8)
Depreciation & Amortization 13.3 13.0 8.4 3.7 1.4 0.2
Deferred Income Tax 0.9 0 0 0 4.7 0
Stock Based Compensation 12.7 14.6 10.7 4.7 0.9 0.1
Other Operating Activities (1.2) 11.3 1.9 1.2 0.4 225.9
Change in Working Capital (9.3) 9.4 123.9 (2.8) 4.9 2.3
Cash From Operations (110.1) (88.3) 14.1 (89.0) (41.3) (16.2)
INVESTING CASH FLOW
Capital Expenditures 0 (13.7) (30.6) (45.0) (9.8) (2.5)
Other Items 47.5 74.9 17.5 (253.4) (12.9) (17.4)
Cash From Investing Activities 47.5 61.1 (13.1) (298.3) (22.8) (19.8)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0
Total Debt Repaid 0 (10.2) 0 0 9.7 0
Dividends Paid 0 0 0 0 0 0
Other Financing Activities 74.6 0 0 196.2 38.0 74.8
Cash From Financing Activities 74.6 (9.7) 27.2 417.8 47.7 74.8
CHANGE IN CASH
Net Change In Cash 11.9 (36.9) 28.1 30.4 (16.3) 38.8
FREE CASH FLOW
Free Cash Flow (110.3) (102.1) (16.6) (134.0) (51.1) (18.6)